East Asia may have a better 1-year survival following an acute heart failure episode compared with Europe: results from an international observational cohort

Authors	AKIYAMA E. VAN AELST L.N.L. ARRIGO M. LASSUS J. MIRO O. CELUTKIENE J. CHOI D.J. COHEN-SOLAL A.. ISHIHARA S. KAJIMOTO K. LARIBI S. MAGGIONI A.P. MOTIEJUNAITE J. MUELLER C. PAŘENICA Jiří PARK J.J. SATO N. ŠPINAR Jindřich ZHANG J. ZHANG Y.H. KIMURA K. TAMURA K. GAYAT E. MEBAZAA A.
Year of publication	2018
Type	Article in Periodical
Magazine / Source	European Journal of heart Failure
MU Faculty or unit	Faculty of Medicine
Citation
Doi	http://dx.doi.org/10.1002/ejhf.1152
Keywords	acute heart failure
Description	Acute heart failure (AHF) is a major health problem worldwide and trials to assess novel therapies are increasingly global, as a means to reduce costs, expedite timelines, provide broad applicability, and satisfy regulatory authorities.The significant geographic differences in patient characteristics, outcomes, and treatment effect may affect trial results and raise important questions about generalizability of the results to a broader population.